Morgan Stanley Maintains Overweight on RH, Lowers Price Target to $210

Benzinga Newsdesk www.benzinga.com Negative 82.5%

Neg 82.5% Neu 0% Pos 0%

Morgan Stanley analyst Simeon Gutman maintains RH (NYSE:RH) with a Overweight and lowers the price target from $240 to $210.